98
Views
0
CrossRef citations to date
0
Altmetric
RESPONSE TO LETTER

Antibiotic Susceptibility Pattern and Bacterial Spectrum Among Patients with External Eye Infections at Menelik II Referral Hospital in Addis Ababa, Ethiopia [Response to Letter]

ORCID Icon, ORCID Icon, , &
Pages 1967-1969 | Published online: 21 Apr 2022

References

  • Woreta AN, Kebede HB, Tilahun Y, Teklegiorgis SG, Abegaz WE. Antibiotic susceptibility pattern and bacterial spectrum among patients with external eye infections at Menelik II Referral Hospital in Addis Ababa, Ethiopia. Infect Drug Resist. 2022;15:765–779. doi:10.2147/IDR.S352098
  • The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 12.0; 2022. Available from: http://www.eucast.org. Accessed April 4, 2022.
  • Leclercq R, Canton R, Brown DFJ, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2013;19:141–160. doi:10.1111/j.1469-0691.2011.03703.x
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility testing. In: CLSI Supplement M100. 31st ed. Vol. 41. No.3 Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2021:M100–Ed 31.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility testing. In: CLSI Supplement M100. 31st ed. Vol. 41. No.3 Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2020:M100–Ed 30.
  • CLSI. Performance standards for antimicrobial disk susceptibility testing. In: CLSI Supplement M100. 28th ed. Vol. 38. Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2018:M02–A12.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: CLSI Supplement M100. 27th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
  • Liu J, Wang R, Fang M. Clinical and drug resistance characteristics of Providencia stuartii infections in 76 patients. J Int Med Res. 2020;48(10):300060520962296. doi:10.1177/0300060520962296
  • Penner JL, Preston MA. Differences among Providencia species in their in vitro susceptibilities to five antibiotics. Antimicrob Agents Chemother. 1980;18(6):868–871. doi:10.1128/AAC.18.6.868
  • Woods TD, Watanakunakorn C. Bacteremia due to Providencia stuartii: a review of 49 episodes. South Med J. 1996;89(2):221–224. doi:10.1097/00007611-199602000-00013
  • Bonfiglio G, Perilli M, Stefani S, Amicosante G, Nicoletti G. Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae: an Italian survey. Int J Antimicrob Agents. 2002;19(3):213–217. doi:10.1016/s0924-8579()00497-601
  • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. In: NCCLS Document M100-S5. Vol. 14. Villanova, PA: National Committee for Clinical Laboratory Standards; 1994.